ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
While the role of ASLX1 in haematopoiesis and leukaemia has been heavily studied, the role of ASLX2 is unclear. Here the authors show that ASLX2 is required for normal haematopoietic stem cell self-renewal whereas Asxl2 loss promotes leukemogenesis, thus explaining the frequently observed mutations...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4858a0bedd1541a2a819f03ad5087413 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4858a0bedd1541a2a819f03ad5087413 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4858a0bedd1541a2a819f03ad50874132021-12-02T15:38:39ZASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia10.1038/ncomms154292041-1723https://doaj.org/article/4858a0bedd1541a2a819f03ad50874132017-05-01T00:00:00Zhttps://doi.org/10.1038/ncomms15429https://doaj.org/toc/2041-1723While the role of ASLX1 in haematopoiesis and leukaemia has been heavily studied, the role of ASLX2 is unclear. Here the authors show that ASLX2 is required for normal haematopoietic stem cell self-renewal whereas Asxl2 loss promotes leukemogenesis, thus explaining the frequently observed mutations in AML patientsJean-Baptiste MicolAlessandro PastoreDaichi InoueNicolas DuployezEunhee KimStanley Chun-Wei LeeBenjamin H. DurhamYoung Rock ChungHana ChoXiao Jing ZhangAkihide YoshimiAndrei KrivtsovRichard KocheEric SolaryAmit SinhaClaude PreudhommeOmar Abdel-WahabNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-13 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Jean-Baptiste Micol Alessandro Pastore Daichi Inoue Nicolas Duployez Eunhee Kim Stanley Chun-Wei Lee Benjamin H. Durham Young Rock Chung Hana Cho Xiao Jing Zhang Akihide Yoshimi Andrei Krivtsov Richard Koche Eric Solary Amit Sinha Claude Preudhomme Omar Abdel-Wahab ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia |
description |
While the role of ASLX1 in haematopoiesis and leukaemia has been heavily studied, the role of ASLX2 is unclear. Here the authors show that ASLX2 is required for normal haematopoietic stem cell self-renewal whereas Asxl2 loss promotes leukemogenesis, thus explaining the frequently observed mutations in AML patients |
format |
article |
author |
Jean-Baptiste Micol Alessandro Pastore Daichi Inoue Nicolas Duployez Eunhee Kim Stanley Chun-Wei Lee Benjamin H. Durham Young Rock Chung Hana Cho Xiao Jing Zhang Akihide Yoshimi Andrei Krivtsov Richard Koche Eric Solary Amit Sinha Claude Preudhomme Omar Abdel-Wahab |
author_facet |
Jean-Baptiste Micol Alessandro Pastore Daichi Inoue Nicolas Duployez Eunhee Kim Stanley Chun-Wei Lee Benjamin H. Durham Young Rock Chung Hana Cho Xiao Jing Zhang Akihide Yoshimi Andrei Krivtsov Richard Koche Eric Solary Amit Sinha Claude Preudhomme Omar Abdel-Wahab |
author_sort |
Jean-Baptiste Micol |
title |
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia |
title_short |
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia |
title_full |
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia |
title_fullStr |
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia |
title_full_unstemmed |
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia |
title_sort |
asxl2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/4858a0bedd1541a2a819f03ad5087413 |
work_keys_str_mv |
AT jeanbaptistemicol asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT alessandropastore asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT daichiinoue asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT nicolasduployez asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT eunheekim asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT stanleychunweilee asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT benjaminhdurham asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT youngrockchung asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT hanacho asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT xiaojingzhang asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT akihideyoshimi asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT andreikrivtsov asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT richardkoche asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT ericsolary asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT amitsinha asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT claudepreudhomme asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia AT omarabdelwahab asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia |
_version_ |
1718386106981941248 |